Literature DB >> 11703839

[Human african trypanosomiasis: A history of its therapies and their failures].

G Ollivier1, D Legros.   

Abstract

This paper gives an overview of the treatment of Human African Trypanosomiasis from the early 20th century until today.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11703839     DOI： 10.1046/j.1365-3156.2001.00753.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN： 1360-2276            Impact factor:   2.622


  6 in total

Review 1.  Human African trypanosomiasis in South Sudan: how can we prevent a new epidemic?

Authors:  José A Ruiz-Postigo; José R Franco; Mounir Lado; Pere P Simarro
Journal:  PLoS Negl Trop Dis       Date:  2012-05-29

2.  Trypanosomiasis relapse after melarsoprol therapy, Democratic Republic of Congo, 1982-2001.

Authors:  Jacques Pépin; Bokelo Mpia
Journal:  Emerg Infect Dis       Date:  2005-06       Impact factor: 6.883

3.  Melarsoprol sensitivity profile of Trypanosoma brucei gambiense isolates from cured and relapsed sleeping sickness patients from the Democratic Republic of the Congo.

Authors:  Patient Pyana Pati; Nick Van Reet; Dieudonné Mumba Ngoyi; Ipos Ngay Lukusa; Stomy Karhemere Bin Shamamba; Philippe Büscher
Journal:  PLoS Negl Trop Dis       Date:  2014-10-02

4.  Enhanced heterosexual transmission hypothesis for the origin of pandemic HIV-1.

Authors:  João Dinis de Sousa; Carolina Alvarez; Anne-Mieke Vandamme; Viktor Müller
Journal:  Viruses       Date:  2012-10-03       Impact factor: 5.048

Review 5.  Treatment options for second-stage gambiense human African trypanosomiasis.

Authors:  Gilles Eperon; Manica Balasegaram; Julien Potet; Charles Mowbray; Olaf Valverde; François Chappuis
Journal:  Expert Rev Anti Infect Ther       Date:  2014-09-10       Impact factor: 5.091

Review 6.  The Drugs of Sleeping Sickness: Their Mechanisms of Action and Resistance, and a Brief History.

Authors:  Harry P De Koning
Journal:  Trop Med Infect Dis       Date:  2020-01-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.